-+ 0.00%
-+ 0.00%
-+ 0.00%

Sanofi SA Acquires Blueprint Medicines, Establishing New Subsidiary Focused on Rare Immunology Diseases

Reuters·07/18/2025 05:00:18

Please log in to view news